Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 16/20 | 0.56 |
| ▸ | CYP1B1 | Q16678 | 16/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 15/20 | 0.56 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.49 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP4B1 | P13584 | 1/20 | 0.49 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.49 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.49 |
| ▸ | CYP2A7 | P20853 | 1/20 | 0.49 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.49 |
| ▸ | CYP2F1 | P24903 | 1/20 | 0.49 |
| ▸ | CYP2C18 | P33260 | 1/20 | 0.49 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14536860 | 0.90 | CYP1A1 (0.44) | CYP1A1CYP1B1CYP1A2NFE2L2CYP19A1 | |
| SCHEMBL13127034 | 0.86 | MEN1 (0.50) | CYP1A1CYP1B1CYP1A2NFE2L2CYP19A1 | |
| SCHEMBL10069726 | 0.85 | CYP1A1 (0.44) | CYP1A1CYP1B1CYP1A2NFE2L2CYP3A4 | |
| SCHEMBL13126950 | 0.85 | CYP1A2 (0.39) | CYP1A1CYP1B1CYP1A2NFE2L2CYP19A1 | |
| SCHEMBL14536925 | 0.84 | CYP1A1 (0.46) | CYP1A1CYP1B1CYP1A2MEN1KMT2A | |
| SCHEMBL10069212 | 0.84 | CYP1A2 (0.63) | CYP1A1CYP1B1CYP1A2NFE2L2CYP19A1 | |
| SCHEMBL13117095 | 0.83 | CYP1A1 (0.38) | CYP1A1CYP1B1CYP1A2NFE2L2CYP19A1 | |
| SCHEMBL10069209 | 0.81 | CYP1A1 (0.58) | CYP1A1CYP1B1CYP1A2NFE2L2CYP19A1 | |
| SCHEMBL13127036 | 0.80 | TRPA1 (0.49) | CYP1A1CYP1B1CYP1A2NFE2L2CYP19A1 | |
| SCHEMBL13822099 | 0.80 | NFE2L2 (0.35) | CYP1A1CYP1B1CYP1A2NFE2L2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8124626-B2 | Methods of treating inflammations and infections with pyridinium salts | MYCOSOL, INC. (US) | 2012-02-28 | — | — | US | disclosed |
| US-7820696-B2 | Compounds and methods for controlling fungi, bacteria and insects | MYCOSOL, INC. (US) | 2010-10-26 | — | — | US | disclosed |
| US-20100267716-A1 | METHODS OF TREATING INFLAMMATIONS AND INFECTIONS WITH PYRIDINIUM SALTS | KLEIN RICHARD B | 2010-10-21 | — | — | US | disclosed |
| US-7547444-B1 | Methods for controlling fungi and bacteria | MYCOSOL, INC. (US) | 2009-06-16 | — | — | US | disclosed |
| US-20090137639-A1 | METHODS FOR CONTROLLING FUNGI AND BACTERIA | MYCOSOL, INC. | 2009-05-28 | — | — | US | disclosed |
| US-20070213299-A1 | COMPOUNDS AND METHODS FOR CONTROLLING FUNGI, BACTERIA AND INSECTS | MYCOSOL, INC. | 2007-09-13 | — | — | US | disclosed |
| US-7220761-B2 | Compounds and methods for controlling fungi, bacteria and insects | MYCOSOL, INC. (US) | 2007-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213299-A1 | COMPOUNDS AND METHODS FOR CONTROLLING FUNGI, BACTERIA AND INSECTS | BLVRB, PNPO, PLPBP | CYP1A1 1805/4885CYP1B1 1069/4885CYP1A2 1498/4885 |
| US-20090137639-A1 | METHODS FOR CONTROLLING FUNGI AND BACTERIA | PNPO, BLVRB, DPM1 | CYP1A1 1809/4885CYP1B1 1570/4885CYP1A2 1597/4885 |
| US-20100267716-A1 | METHODS OF TREATING INFLAMMATIONS AND INFECTIONS WITH PYRIDINIUM SALTS | PNPO, PLPBP, TPMT | CYP1A1 1400/4885CYP1B1 1410/4885CYP1A2 821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.